Miriam O'Sullivan - 01 Nov 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Nov 2026, 18:14:41 UTC
Prior SEC filing
18 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Susan Thompson, Attorney-in-Fact
Filing notes and source

Key filing fact

Miriam O'Sullivan filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 03 Nov 2026.

Key facts

  • This page summarizes Miriam O'Sullivan's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Nov 2026, 18:14.

Change

  • Previous filing in this sequence was filed on 18 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002048285 Primary reporting owner

O'Sullivan Miriam

Relationship
SVP, Chief HR Officer
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH
Signature
/s/ Susan Thompson, Attorney-in-Fact
Signature date
03 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSX transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,871
Change %
+22%
Price
$0.000000*
Shares after
21,437
Date
01 Nov 2026
Ownership
Direct
Footnotes
F1, F2
BSX transaction

Common Stock

Tax liability

Transaction value
Shares
-1,872
Change %
-8.7%
Price
$41.98*
Shares after
19,565
Date
01 Nov 2026
Ownership
Direct
BSX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,731
Date
01 Nov 2026
Ownership
By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-3,871
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,871
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

Footnote F2

Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.

Footnote F3

Shares of common stock will be issued to the reporting person in full on November 1, 2026, the third anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .